In human breast cancer cell lines, it has been found that an ALDEFLUOR-positive CD44+ subpopulation of CD133+ cells was more enriched for tumor-initiating cells than ALDEFLUOR-negative CD44−/CD133+ cells [42]. This evidence concerns the gene PROM1 and breast carcinoma.